Heffernan Michael Thomasinsider trades
In SEC Form 4 filings, Heffernan Michael Thomas is listed as Director of Trevi Therapeutics, Inc. (TRVI). In the last 90 days, Heffernan Michael Thomas sold $595.8K of Trevi Therapeutics, Inc. (TRVI) on the open market and bought none. All 4 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| TRVITrevi Therapeutics, Inc. | Director | 8 | Sep 17 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-17
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| TRVITrevi Therapeutics, Inc. | Sep 15 | Sep 17 | M | 18,421 | $3.04 | $56,000 | 24,772 | Yes | Form 4 |
| TRVITrevi Therapeutics, Inc. | Sep 15 | Sep 17 | S | 18,321 | $15.09 | Sale −$276,464 | 6,451 | Yes | Form 4 |
| TRVITrevi Therapeutics, Inc. | Sep 15 | Sep 17 | S | 100 | $15.88 | Sale −$1,588 | 6,351 | Yes | Form 4 |
| TRVITrevi Therapeutics, Inc. | Sep 15 | Sep 17 | M | 21,052 | $3.33 | $70,103 | 27,403 | Yes | Form 4 |
| TRVITrevi Therapeutics, Inc. | Sep 15 | Sep 17 | S | 20,952 | $15.09 | Sale −$316,166 | 6,451 | Yes | Form 4 |
| TRVITrevi Therapeutics, Inc. | Sep 15 | Sep 17 | S | 100 | $15.88 | Sale −$1,588 | 6,351 | Yes | Form 4 |
| TRVITrevi Therapeutics, Inc. | Sep 15 | Sep 17 | M · derivative | 18,421 | $3.04 | $56,000 | not reported | Yes | Form 4 |
| TRVITrevi Therapeutics, Inc. | Sep 15 | Sep 17 | M · derivative | 21,052 | $3.33 | $70,103 | not reported | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.